Insmed | INSM - Trade Creditors

Stock Price
135.17
Daily Change
-8.66 -6.02%
Monthly
-8.86%
Yearly
93.96%
Q2 Forecast
132.28

Insmed reported $79.91M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
DBV Technologies USD 39.82M 972K Sep/2025
Gilead Sciences USD 715M 93M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Novartis USD 4.46B 99M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025